Review Open Access Cancer Drug Resistance Exosomal lncRNAs: the newest promising liquid biopsy

Abstract : LncRNAs are defined as RNA transcripts greater than 200 nucleotides in length that have no or limited protein-coding potential. Basal expression of lncRNAs appeared important for various homeostatic processes, like gene imprinting cell differentiation and organogenesis. Moreover, it has been demonstrated that lncRNAs play an important role in tumorigenesis and metastasis. Some lncRNAs were stably detected in exosomes, which are widely found in body fluids. Several studies validated the use of exosomal lncRNAs as minimally invasive diagnostic and prognostic markers in several types of cancers. In addition, exosomal lncRNAs have been associated with drug resistance of tumor cells, suggesting a clinical application in cancer-targeted therapy. Despite the recent increase of studies on exosomal lncRNAs, their clinical significance in cancer diagnosis, prognosis and treatment needs to be fully explored. The methodologies for their detection with high purity and accuracy must be also improved in order to implement their use in clinical routine. This review aims to summarize the main recent technologies available for the isolation of exosomal lncRNAs, their status as a liquid biopsy as well as their future perspectives.
Complete list of metadatas

Cited literature [121 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02319217
Contributor : Dominique Heymann <>
Submitted on : Thursday, October 17, 2019 - 5:33:45 PM
Last modification on : Saturday, October 19, 2019 - 1:29:45 AM

File

CDR-2019-69.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Marta Tellez-Gabriel, Dominique Heymann. Review Open Access Cancer Drug Resistance Exosomal lncRNAs: the newest promising liquid biopsy. Cancer Drug Resistance, oaepublish, 2019, ⟨10.20517/cdr.2019.69⟩. ⟨inserm-02319217⟩

Share

Metrics

Record views

44

Files downloads

51